(58 days)
Not Found
No
The description focuses on automated laboratory processes and standard data analysis algorithms, with no mention of AI or ML terms or concepts.
No.
The device is an in vitro diagnostic (IVD) immunoassay analyzer, not a therapeutic device. It is used to automate microplate-based assays for diagnostic purposes, such as measuring hormone levels or antibodies, which aids in diagnosis but does not provide therapy.
Yes
The "Intended Use / Indications for Use" section explicitly states that "CODA is an integrated immunoassay analyzer intended for the automation of microplate based assays for in vitro diagnostic use."
No
The device description explicitly states that the system includes hardware components such as a sampler, plate-shaker, incubator, washer, reader, and robotics housed in a single compact Main Unit, in addition to the software.
Yes, this device is an IVD (In Vitro Diagnostic).
The "Intended Use / Indications for Use" section explicitly states: "CODA is an integrated immunoassay analyzer intended for the automation of microplate based assays for in vitro diagnostic use."
This statement directly identifies the device's purpose as being used for diagnostic testing performed outside of the body (in vitro).
N/A
Intended Use / Indications for Use
CODA is an integrated immunoassay analyzer intended for the automation of microplate based assays for in vitro diagnostic use. The system is open, such that a variety of microplate-based enzyme immunoassays (EIA's) can be programmed and run on the instrument. The sample and reagent pipettes, incubator, washer, reader and robotics are housed in the compact benchtop unit. CODA Operation and Data Management software operates in the Windows 95 environment utilizing icon-based commands for operator ease of use.
Product codes
JJI
Device Description
The Bio-Rad Coda Automated EIA Analyzer (Coda) is a compact, integrated immunoassay system designed for the automation of microplate based (8 wells by 12 strips) chemistries. The sampler, plate-shaker, incubator, washer, reader and robotics are housed in a single compact Main Unit. An external computer handles the operation and data management using software contained on a CD-ROM which operates in the Windows 95 environment.
Enzyme immunoassay (EIA) typically involves the addition of a defined volume of sample to a series of plastic microtitre wells which have been pre-coated with antigen or antibody. The wells are sometimes washed to remove unbound ligand before addition of enzyme conjugate to each well. After incubation, substrate is added followed by a second incubation. The enzyme reaction is "stopped" and the colored reactant product is measured by absorbance at a defined wavelength. The absorbance values of the unknowns are compared to absorbance of calibrators to determine the concentration of the ligand in the sample. The Coda provides an integrated, automated approach to carrying out the above steps all under control of the computer and associated software. All the steps may be programmed into a complete protocol or individual steps may be performed in a manual mode. The Coda is therefore virtually usable with any assay kit using microtite plates. Output from the spectrophotometer is measured by the computer. Calculation, curve-fitting, result interpretation and other aspects of data management and analysis are automatically performed by the software algorithms.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies
The performance of the Bio-Rad Coda Automated EIA Analyzer was evaluated for precision, sensitivity, carry over, and accuracy.
Precision studies:
- Study type: Precision studies done according to NCCLS Evaluation protocol, Vol. 12, No 4, EP5-T2, Appendix C, pp 31-39.
- Sample size: Twenty samples each of low, mid-range and high control plus a Bio-Rad anemia control (AN).
- Key results:
- Within-Run % CV for the low control was 8.6
- Within-Run % CV for the mid-range control 7.1
- High control was consistently creater that 25 ulU/mL.
- %CV for the anemia control was 9.5.
- Total precision for the low control was 9.6%
- Total precision for the mid-range control 7.7%
- High control was consistently greater than 25 ulU/mL.
- Total precision for the anemia control was 14.0%.
Sensitivity:
- Key results: The measuring range (sensitivity) determined that the lowest level of TSH that could be distinguished from the zero standard is 0.034 ulU/mL at the 95% confidence limit on the Coda.
Accuracy / Correlation study:
- Study type: Correlation study to determine accuracy, comparing Bio-Rad Coda Automated EIA Analyzer to the Bio-Rad Radias Immunoassay System, following NCCLS Document EP9-T.
- Sample size: 111 samples
- Key results: correlation coefficient, "r", was 0.995.
Key Metrics
- Within-Run % CV for low control: 8.6
- Within-Run % CV for mid-range control: 7.1
- %CV for anemia control: 9.5
- Total precision for low control: 9.6%
- Total precision for mid-range control: 7.7%
- Total precision for anemia control: 14.0%
- Sensitivity (lowest TSH distinguishable from zero standard): 0.034 ulU/mL at 95% confidence limit
- Correlation coefficient "r": 0.995
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 862.2500 Enzyme analyzer for clinical use.
(a)
Identification. An enzyme analyzer for clinical use is a device intended to measure enzymes in plasma or serum by nonkinetic or kinetic measurement of enzyme-catalyzed reactions. This device is used in conjunction with certain materials to measure a variety of enzymes as an aid in the diagnosis and treatment of certain enzyme-related disorders.(b)
Classification. Class I (general controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to § 862.9.
0
Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized eagle with three stripes forming its body and wings. The words "DEPARTMENT OF HEALTH & HUMAN SERVICES • USA" are arranged in a circle around the eagle.
Food and Drug Administration 2098 Gaither Road Rockville MD 20850
John W. Nelson JUL 30 1997 .• Manager, Regulatory Affairs • Bio-Rad Laboratories 4000 Alfred Nobel Drive Hercules, California 94547-1803
K972024 Re : Coda™ Automated EIA Analyzer Requlatory Class: I Product Code: JJI May 30, 1997 Dated: Received: June 2, 1997
Dear Mr. Nelson:
We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions The general controls provisions of the Act of the Act. include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Requlations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the current Good Manufacturing Practice requirement, as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic (QS) inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP requlation may result in regulatory In addition, FDA may publish further announcements action. concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal Laws or Requlations.
1
Page 2
Under the Clinical Laboratory Improvement Amendments of 1988 (CLIA-88), this device may require a CLIA complexity categorization. To determine if it does, you should contact the Centers for Disease Control and Prevention (CDC) at (770) 488-7655.
This letter will allow you to begin marketing your device as described in your 510 (k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling requlation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4588. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its internet address "http://www.fda.gov/cdrh/dsmamain.html".
Sincerely yours,
Steven Gutman
Steven I. Gutman, M.D., M.B.A. Director Division of Clinical Laboratory Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
2
K yiday
JUL 300 1997
APPENDIX B
SUMMARY OF SAFETY AND EFFECTIVENESS
3
Image /page/3/Picture/0 description: The image shows the logo for Bio-Rad. The text "BIO-RAD" is written in white, bold, sans-serif font. The plus sign in the middle of the text is slightly larger than the other letters. The text is set against a black, rounded rectangle.
Bio-Rad Laboratories
Diagnostics Group 4000 Alfred Nobel Dr. Hercules, CA 94547-1803 Telephone: 510 724-7000 Fax: 510 741-5824
SUMMARY OF SAFETY AND EFFECTIVENESS
| Submitter: | Bio-Rad Laboratories, Inc.
Clinical Systems Division
4000 Alfred Nobel Drive
Hercules, California 94547
Phone 1-510-741-6015
FAX 1-510-741-5824 |
|----------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Contact Person: | John W. Nelson
Manager, Regulatory Affairs |
| Date Prepared: | May 30, 1997 |
| Product Trade Name: | Bio-Rad Coda™ Automated EIA Analyzer |
| Common Name: | Coda |
| Classification Name: | Enzyme Analyzer, for Clinical Use, 75JJI |
| Predicate Devices | 1. Radius™ Immunoassay System,
Bio-Rad Laboratories, K930898. |
| | 2. ACS 180 Automated Chemiluminescence
System, Ciba Corning, K902336. |
| | 3. Abbott IMX2 Analyzer, Abbott
Laboratories, K931970. |
To establish substantial equivalence to an existing device, and thus establish the safety and effectiveness of the Bio-Rad Coda Automated EIA Analyzer, the Bio-Rad Coda Automated EIA Analyzer has been compared to the Bio-Rad Radias Immunoassay System K930898. A review of the intended use of each system shows them to be essentially the same in that they are capable of measuring a number of analytes based on the Enzyme Immunoassay (EIA) principle. The intended use of the Bio-Rad Coda Automated EIA Analyzer is stated as: CODA is an integrated immunoassay analyzer intended for the automation of microplate based assays for in vitro diagnostic use. The system is open, such that a variety of microplate-based enzyme immunoassays (EIA's) can be programmed and run on the instrument. The sample and reagent pipettes, incubator, washer, reader and robotics are housed in the compact benchtop unit. CODA Operation and Data Management software operates in the Windows 95 environment utilizing icon-based commands for operator ease of use. The intended use of the Bio-Rad Radias Immunoassay System is stated as: Radias is a fully automated immunoassay system utilizing ELISA based assays for in vitro diagnostic use.
4
The Bio-Rad Coda Automated EIA Analyzer (Coda) is a compact, integrated immunoassay system designed for the automation of microplate based (8 wells by 12 strips) chemistries. The sampler, plate-shaker, incubator, washer, reader and robotics are housed in a single compact Main Unit. An external computer handles the operation and data management using software contained on a CD-ROM which operates in the Windows 95 environment.
Enzyme immunoassay (EIA) typically involves the addition of a defined volume of sample to a series of plastic microtitre wells which have been pre-coated with antigen or antibody. The wells are sometimes washed to remove unbound ligand before addition of enzyme conjugate to each well. After incubation, substrate is added followed by a second incubation. The enzyme reaction is "stopped" and the colored reactant product is measured by absorbance at a defined wavelength. The absorbance values of the unknowns are compared to absorbance of calibrators to determine the concentration of the ligand in the sample. The Coda provides an integrated, automated approach to carrying out the above steps all under control of the computer and associated software. All the steps may be programmed into a complete protocol or individual steps may be performed in a manual mode. The Coda is therefore virtually usable with any assay kit using microtite plates. Output from the spectrophotometer is measured by the computer. Calculation, curve-fitting, result interpretation and other aspects of data management and analysis are automatically performed by the software algorithms.
Bio-Rad Radias Immunoassay System (Radias) is a fully automated immunoassay system designed for high-capacity which, like the Coda, is based on ElA. All assay operations, including pipetting, diluting and incubating samples and reagents are performed by the Radius. Based on a "worklist" the Radius determines the quantities and types of reagents and microwell "strips" that will be needed for the run. The Radias can do multiple assays on the same sample. All reagents required by the Radius are supplied by Bio-Rad Laboratories in Radias compatible "troughs". Calculation, curve-fitting, result interpretation and other aspects of data management and analysis are automatically performed by the software algorithms.
The performance of the Bio-Rad Coda Automated EIA Analyzer was evaluated for precision, sensitivity, carry over, and accuracy. The precision studies were done according to NCCLS Evaluation protocol, Vol. 12, No 4, EP5-T2, Appendix C, pp 31-39. Twenty samples each of low, mid-range and high control plus a Bio-Rad anemia control (AN) were analyzed. The Within-Run % CV for the low control was 8.6 and for the mid-range control 7.1. The high control was consistently creater that 25 ulU/mL. The %CV for the anemia control was 9.5. Total precision for the low control was 9.6% and for the mid-range control 7.7% . Again the high control was consistently greater than 25 ulU/mL. The total precision for the anemia control was 14.0%. The measuring range (sensitivity) determined that the lowest level of TSH that could be distinguished from the zero standard is 0.034 ulU/mL at the 95% confidence limit on the Coda.
The correlation study, to determine accuracy, of Bio-Rad Coda Automated EIA Analyzer compared to the Bio-Rad Radias Immunoassay System followed NCCLS Document EP9-T. For 111 samples, the correlation coefficient, "r", was 0.995.
When comparing the Bio-Rad Coda Automated EIA Analyzer to the predicate, it can be concluded from the correlation study and similarities of the general characteristics of the two systems (Appendix C), that the Bio-Rad Coda Automated EIA Analyzer and the Bio-Rad Radias Immunoassay System are substantially equivalent. Based on the establishment of substantial equivalence, the safety and effectiveness of the Bio-Rad Coda Automated ElA Analyzer is confirmed.
5
Statement of Intended Use
Page 1 of 1
510(k) Number (If Known)
Bio-Rad Coda™ Automated EIA Analyzer. Device Name:
CODA is an integrated immunoassay analyzer intended for the ndications for Use: automation of microplate based assays for in vitro diagnostic use. The system is open, such that a variety of microplate-based enzyme immunoassays (EIA's) can be programmed and run on the instrument. The sample and reagent pipettes, incubator, washer, reader and robotics are housed in the compact benchtop unit. CODA Operation and Data Management software operates in the Windows 95 environment utilizing icon-based commands for operator ease of use.
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDHR, Office of Device Evaluation (ODE)
Prescription Use
(Per 21 CFR 801.109)
OR Over-The-Counter Use _
(Division Sign-Off)
Division of Clinical Laboratory Dexices
510(k) Number K972024
Laboratory Dexices